![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Tiantai Pharmaceutical Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Amphotericin B, Process I, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-150 - Rev 00
This Chemical Type CEP, issued on June 17, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1292 associated with this CEP further emphasizes